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ABSTRACT
Pattern recognition receptors (PRRs) are responsible for Aspergillus fumigatus recognition by 
innate immunity and its subsequent immune signaling. The triggering receptor expressed on 
myeloid cells 1 (TREM1) is a recently characterized pro-inflammatory receptor constitutively 
expressed on the surface of neutrophils and macrophages. A soluble form (sTREM1) of this protein 
that can be detected in human body fluids has been identified. Here we investigated the role of 
TREM1 during invasive pulmonary aspergillosis (IPA). IPA patients displayed significantly higher 
levels of sTREM1 in bronchoalveolar lavages when compared to control patients. Functional 
analysis in TREM1 showed that the levels of sTREM1 and TREM1 pathway-related cytokines were 
influenced by single nucleotide polymorphisms in TREM1. In addition, we confirmed a role of 
TREM1 on antifungal host defense against A. fumigatus in a murine model of IPA. TREM1 
deficiency increased susceptibility to infection in the immunosuppressed murine host. Deletion 
of TREM1 showed delayed innate and adaptive immune responses and impaired pro-inflamma-
tory cytokine responses. The absence of TREM1 in primary macrophages attenuated the TLR 
signaling by altering the expression of both receptor and effector proteins that are critical to the 
response against A. fumigatus. In this study, and for the first time, we demonstrate the key role for 
the TREM1 receptor pathway during IPA.
ARTICLE HISTORY
Received 4 August 2020  
Revised 11 December 2020  




biomarkers and fungal 
immune response
Introduction
Invasive Pulmonary Aspergillosis (IPA) is a severe dis-
ease that can develop in immunocompromised hosts, 
such as individuals with neutropenia, those treated for 
hematological malignancies, and recipients of hemato-
poietic stem cell (HSCT) or solid organ transplantation 
(SOT) [1–3]. Despite improvements in antifungal ther-
apy and the availability of better diagnostic tools, the 
detection, definitive diagnosis, and treatment of this 
disease remains challenging.
IPA usually starts in the lungs via the inhalation of 
airborne conidia. There, innate immunity is mediated 
by neutrophils, monocytes, and alveolar macrophages, 
which are the first line of defense against A. fumigatus 
and responsible for local inflammatory responses 
against this pathogen [4,5]. The recognition of A. fumi-
gatus by macrophages is performed by pattern 
recognition receptors, which include C-type lectin and 
toll-like receptors (TLRs) that recognize specific fungal 
components [6–8]. Over the last decade, an additional 
family of evolutionary conserved innate immune recep-
tors has been identified: the triggering receptors 
expressed on myeloid cells (TREMs) [9]. Among 
them, TREM1 is the best-characterized member of the 
TREM family of receptors. TREM1, belonging to the Ig 
superfamily, is a cell-surface activating receptor with a 
single extracellular V-type Ig-like domain, a transmem-
brane region containing charged lysine residues, and a 
short cytoplasmic tail lacking signaling motifs. Receptor 
domains of TREM1 include both activating and inhibi-
tory isoforms whose ligands are unknown [10].
TREM1 is constitutively expressed by neutrophils 
and macrophages and its expression is further up-regu-
lated by microbial components [11]. Although the pre-
cise role of TREM1 has not yet been clearly defined, it 
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is well documented that TREM1 amplifies TLR4 and 
TLR2 inflammatory signaling [12,13]. In addition, 
TREM1 can be secreted as a soluble form (sTREM1), 
and therefore it has been utilized as a diagnostic marker 
for inflammatory processes including infections. For 
instance, the presence of sTREM1 in samples from 
bronchoalveolar lavage (BAL) fluid from mechanically 
ventilated patients has been shown to be a good indi-
cator of infectious pneumonia [14].
Compared to sepsis and bacterial pneumonia, stu-
dies evaluating the role of TREM1 in aspergillosis are 
relatively limited. Increased TREM1 expression is 
observed in monocyte-derived macrophages from 
patients with chronic pulmonary aspergillosis, while 
reduced TREM1 expression is observed in individuals 
suffering from allergic bronchopulmonary aspergillosis 
[15]. In addition, TREM1 has been shown to modulate 
the immune response directed against A. fumigatus 
during experimental fungal asthma [16] and in infected 
rat corneal epithelium [17].
In the present study, we aimed to characterize the 
role of TREM1 in IPA. We assessed sTREM1 levels in 
clinical samples of IPA patients compared to controls 
and we tested for TREM1 functionality by assessing 
whether individual genetic variation in TREM1 had an 
impact on the detected levels of sTREM1 and other 
cytokine-driven immune responses against A. fumiga-
tus. In addition to gain a deeper understanding of the 
role of TREM1, we compared the course of A. fumigatus 
infections and immune responses in TREM1-deficient 
(Trem1−/−) and wild-type (Trem1+/+) mice.
Material and methods
Patients and sample collection
Bronchoalveolar lavage (BAL) samples were collected 
from hospitalized adult patients (≥18 years of age) 
during routine diagnostic workup following suspicion 
of infection at the Leuven University Hospitals, Leuven, 
Belgium. Fifty cases of “probable” or “proven” IA were 
identified according to the 2008 standard criteria of the 
European Organization for Research and Treatment of 
Cancer/Mycology Study Group (EORTC/MSG) [18]. 
BAL specimens were collected as described before 
[19]. All samples were stored at −80°C until use. The 
demographic and clinical characteristics of the patients 
enrolled in this study are described in Table 1.
Analysis of sTREM1 and cytokines in human 
BAL
sTREM1 levels and selected cytokines were quantified 
in BALs using customized Human Premixed Multi- 
Analyte Kits (R&D Systems, MN, USA). All determina-
tions were performed in duplicates, and concentrations 
were reported in pg/mL.





(n = 48) P value
Age, no (%)
≤50 years 9 (18.0) 13 (27.1) 0.34
>50 years 41 (82.0) 35 (72.9)
Gender, no (%)
Female 23 (46.0) 21 (43.8) 0.84
Male 27 (54.0) 27 (56.2)
Underlying disease, no (%)
SOT* 12 (24.0) 20 (41.7) 0.22
Acute leukemia 9 (18.0) 10 (20.8)
Allogeneic HSCT 9 (18.0) 6 (12.5)
Chronic lymphoproliferative diseases 7 (14.0) 6 (12.5)
Influenza A (H1N1) 6 (12.0) 0 (0.0)
Chronic lung diseases 2 (4.0) 1 (2.1)
Solid tumors 2 (4.0) 1 (2.1)
Other 3 (6.0) 4 (8.3)
Severe neutropenia, no (%)† 15 (30.0) 5 (10.4) 0.023
BAL cell counts, mean (range)‡
Neutrophils 5.5 (0.0–30.3) 4.5 (0.1–17.3) 0.30
Lymphocytes 4.2 (0–175.7) 1.8 (0.2–17.4) <0.001
GMI, mean (range) 5.1 (1.0–6.9) 0.11 (0.1–0.2) <0.001











SOT, solid organ transplantation; HSCT, hematopoietic stem-cell transplantation; BAL, bronchoalveolar lavage; GMI, galactomannan index; P values were 
calculated by Fisher’s exact probability t-test for categorical variables, or by Student’s t-test or Mann–Whitney U test for continuous variables. *The study 
included 32 patients who received a SOT from lung (n = 26), kidney (n = 2), and liver (n = 2). Among those, 12 were diagnosed with IPA (lung, n = 8; kidney, 
n = 2; and liver, n = 2). †Severe neutropenia was defined as ≤0.5 × 109 cells/L. ‡Cell counts in BAL were expressed as the number ×103 cells/µL. 
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Single nucleotide polymorphism (SNP) 
selection and genotyping
The rs2234237 and rs2234246 SNPs in TREM1 were 
studied. Genomic DNA was isolated from BAL samples 
using QIAcube automated system (Qiagen, Hilden, 
Germany). Genotyping was performed using KASPar 
assays (LGC Genomics, Hertfordshire, UK) in an 
Applied Biosystems 7500 Fast Real-Time PCR system 
(Thermo Fisher Scientific, MA, USA), according to the 
manufacturer’s instructions. Mean call rate for the 
SNPs was >98%. Quality control for the genotyping 
results was achieved with negative controls and ran-
domly selected samples with known genotypes.
Aspergillus fumigatus growth conditions
The ATCC46645 strain was used throughout this work. 
Aspergillus was grown for 2 to 3 days at 37°C on potato 
dextrose agar slants. For all experiments, A. fumigatus 
spores were harvested and prepared as previously 
described [20].
Murine infections
Eight weeks-old male TREM1-deficient (Trem1−/−) and 
wild type (WT) (Trem1+/+) mice, raised on C57BL/6 N 
background, were used. Mice were bred in house at the 
National Center for Microbiology. Immunosuppression 
was induced with 150 mg kg−1 cyclophosphamide 
(Pras-Farma, Barcelona, Spain) administered intraper-
itoneally, and 112 mg kg−1 of Cortisone 21-acetate 
(Sigma, C-3130) administered subcutaneously, both 
on day −3 and −1. On day 0, the animals were anesthe-
tized intramuscularly with 0.1 ml of a mixture of 
KetolarR (ketamine 50 mg ml−1; Pfizer) and 
RompumR (xylazin chlorohydrate 2%; Bayer) at final 
concentrations of 12.5 and 2 mg ml−1, respectively, fol-
lowed by the intranasal inoculation of 30 μl saline sus-
pension containing 2 × 107 conidia per mouse. After 
infection, cyclophosphamide (150 mg kg−1) was used 
every three days until completion of the experiment.
Mice were weighed every 24 hours from the day of 
infection and visual inspection was made twice daily. 
Mice dying of fungal challenge were recorded daily for 
survival analysis. Depending on the experiment, mice 
were culled and whole lungs were collected after two, 
three, or five days post-infection (dpi). We used 10 to 
12 mice per condition for survival, three mice per day 
for immune response and histology analyses. 
Uninfected animals were included as controls in all 
experiments. At least two independent murine infec-
tions were performed.
Histology analyses
Mice were culled and whole lungs were collected from 
2 dpi. Lungs were immediately fixed in 10% neutral- 
buffered formalin. After fixation, lung samples were 
then treated with xylene and embedded in paraffin. 
Five-micron tissue sections were stained with hematox-
ylin and eosin (HE) and sections were examined with a 
Leica DMI 3000B microscope.
Flow cytometry
Whole lung cell suspensions from Trem1+/+ and 
Trem1−/− infected mice at different times were pre-
pared, counted, and stained with appropriate mAbs. 
Details on methods for flow cytometry analyses and 
antibodies are described in the Supplementary 
Methods. Neutrophils were identified by the expression 
of GR-1 hiCD11bhi and monocytes as GR-1−CD11b+. 
To confirm an adequate separation between neutro-
phils and monocytes, the expression of Ly6C, F4/80 
and CD11c was traced in gated GR-1 hiCD11bhi, 
being Ly6Clo, F4/80lo, CD11clo as described before 
(data not shown [21,22]).
Analysis of sTREM1 and cytokines in lysates of 
homogenized murine lungs
sTREM1 concentrations were measured with the 
TREM1 DuoSet (R&D) according to the manufacturer’s 
instructions.
Cytokines were determined in 50-μl samples of whole 
lung homogenates using customized Mouse Premixed 
Multi-Analyte Kits (R&D Systems, MN, USA) and the 
Bio-Plex platform (Bio-Rad Laboratories, Hercules, CA).
Isolation of murine macrophages from the 
peritoneal cavities
Primary macrophages were isolated from the peritoneal 
cavities of mice as described before [23]. After centri-
fugation of the cell suspension, primary macrophages 
were counted using a hemocytometer. A suspension of 
5 × 105 cells/ml in feeding medium RPMI 1640 w/o L- 
glutamine supplemented with 10% heat-inactivated 
fetal bovine serum (FBS) and L-Glutamine–Penicillin– 
Streptomycin was prepared, and 1 ml per well was 
added to 24 well tissue culture plates and incubated 
overnight at 37°C in a 5% CO2-enriched atmosphere. 
The following day the medium was removed, and 1 ml 
of fresh feeding medium containing A. fumigatus 
spores at a cell density of 5 × 105 cells/ml was added 
to each well. Cell stimulation was carried out for 1 or 2 
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and 6 hours at 37°C in the presence of 5% CO2. 
Negative control included non-infected cells.
Internalization of Aspergillus fumigatus conidia
Peritoneal mice macrophages were obtained and stimu-
lated with A. fumigatus conidia as described before. 
Conidia were added to the macrophages and after 1 h 
of incubation at 37°C, all content of the wells was 
discarded, wells were washed three times with PBS 
and the host cells were lysed with water. Content 
wells were collected and plated in serial dilution on 
Sabouraud agar in order to obtain conidia associated 
with cells. Wells without cells were included and after 
the incubation period, all the content was collected and 
plated in serial dilution on Sabouraud agar. CFUs (col-
ony-forming units) were counted after 24 h at 37°C. 
Conidia associated with cells were compared to the 
inoculum of conidia in wells without cells to calculate 
the percentage phagocytosis.
RNA extraction and quantitative PCR (qPCR)
After induction with A. fumigatus during 2 and 
6 hours, the culture medium was removed and wells 
were washed twice using PBS. RNA was isolated from 
TRIzol (Invitrogen Life Technologies) suspended sam-
ples using RNeasy Mini kit from Qiagen. The purified 
RNA was subsequently used for cDNA preparation 
using the ImProm-IITM Reverse Transcription System 
kit (Promega). Primers used for qPCR are described in 
Supplementary table 2. The analysis of gene expression 
was performed using quantitative PCR (qPCR) 
SensiMix™ SYBR® Hi-ROX Kit (Roche Diagnostic) and 
performed in a CFX96 system (Bio-Rad). The actin 
gene was used as housekeeping and fold change in 
gene expression was calculated over non-infected cells 
using the 2−ΔΔCT threshold cycle (CT) method [24].
Statistical analyses
All data were analyzed with GraphPad Prism software. 
Unpaired t-tests were used to determine statistically 
significant differences between experimental groups in 
which p values <0.05 were considered statistically 
significant.
The area under the receiving operating characteristic 
curve (AUCROC) was used to evaluate the ability of 
TREM1 to diagnose IPA. Youden index was computed 
to determine the sTREM1 cutoff level with the highest 
discriminatory power.
Kaplan-Meier survival curves were analyzed by using 
a log-rank (Mantel-Cox) test for significance. A p-value 
<0.01 was considered statistically significant.
Ethics statement
Study approval was obtained for the use of human 
samples from the Ethics Subcommittee for Life and 
Health Sciences of the University of Minho, Portugal 
(protocols 125/014 and 126/014), and the Ethics 
Committee of the University Hospitals of Leuven, 
Belgium.
Murine infections were performed in dedicated facil-
ities of the National Center for Microbiology. The 
project was ethically approved by the Animal Welfare 
Committee of the Instituto de Salud Carlos III and 
performed under the approved Project License 
PROEX 324/16.
Results
TREM1 levels in BAL samples are associated with 
probable and proven IPA
To investigate the role of TREM1 in IPA, we com-
pared the levels of TREM1 in BAL fluids from 
patients diagnosed with IPA and matched controls 
(non-IPA patients). A total of 98 subjects, including 
50 cases of “probable” or “proven” IA according to 
the EORTC/MSG criteria and 48 controls with no A. 
fumigatus infection were included in this study (Table 
1). The distribution and comparison of BAL biomar-
ker levels between different groups of patients are 
shown in Figure 1a. IPA patients showed significantly 
higher levels of sTREM1 than control patients. To 
corroborate its utility for the diagnosis of IPA, we 
analyzed the AUCROC for sTREM1 (Figure 1a). 
sTREM1 demonstrated reasonable sensitivity and spe-
cificity (AUCROC = 0.718; 95% CI, 0.618–0.819; 
p = 0.002) with a cutoff level ≥ 800.8 pg/mL calcu-
lated using Youdens index.
Detection of galactomannan in BAL samples has been 
described as a sensitive test for diagnosing of IPA [25], 
therefore the association between sTREM1 levels in BAL 
and galactomannan was analyzed. We categorized the 
patients into subgroups according to the galactomannan 
index (GMI): GMI <0.5 (identifying controls), and high 
GMI ≥3.0 (associated with a diagnosis with 100% speci-
ficity) [26]. We found that patients with higher levels of 
galactomannan (GMI ≥3.0) also displayed significantly 
elevated concentrations of sTREM1 compared to GMI- 
negative controls (GMI <0.5) which increased the statis-
tical significance to p < 0.001 (p = 0.0006). Likewise, the 
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statistical significance of AUCROC was also increased 
(AUCROC = 0.7545; 95% CI, 0.655–0.854; P < 0.0001) 
(Figure 1b).
TREM1 SNPs can regulate sTREM1 levels and 
inflammatory responses in IPA patients
To examine the functionality of TREM1 in the context 
of IPA, we investigated whether SNPs in TREM1 could 
differentially regulate sTREM1 levels in BAL samples 
from patients with IPA and matched controls. We stu-
died the rs2234237 SNP, a nonsynonymous variation 
(Ser25Thr) located in exon-2 that may influence the 
biologic function of TREM1 [27], and the rs2234246 
SNP, located at gene promoter and described to regulate 
TREM1 expression levels that results in differential 
plasma levels of proteins such as L-selectin [28].
We found that individuals harboring the AA geno-
type at rs2234237 showed higher levels of sTREM1 
when compared to the AT genotype. Statistical differ-
ences were increased among IPA patients. The T allele 
at rs2234246 was associated with increased amounts of 
sTREM1 compared to the homozygous CC genotype in 
IPA patients (Figure 2a). Recent studies identified IL- 
1β, IL-6, IL-8, IL-17A, IL-23, and TNFα as alveolar 
cytokines that were significantly increased in BAL sam-
ples of IPA patients [19]. Since TREM1 acts as an 
amplifier of the immune response and its stimulation 
promotes the release of several pro-inflammatory cyto-
kines [29], we investigated the associations between the 
significance in the above SNPs and the levels of those 
cytokines with an important role in the lung environ-
ment. We found that IPA patients harboring the AA 
genotype at rs2234237 and individuals having the T 
allele for rs2234246 displayed differential levels of IL- 
1β (Figure 2b). Interestingly, genotype-specific differ-
ences were observed, with control and IPA patients 































































Figure 1. a) Left, quantification of sTREM1 levels in BAL samples from patients with IPA (cases, n = 50) compared to controls 
(n = 48). sTREM1 levels were expressed as log10 pg/mL. Data are presented as scatterplots representing individual data points and a 
line indicating the mean value with SD. Right, receiver operating characteristic (ROC) curves used to evaluate the ability of sTREM1 to 
diagnose invasive pulmonary aspergillosis (IPA). B) Left, quantification of sTREM1 levels in BAL samples from patients with IPA and 
high GMI > 3.0 compared to controls. TREM1 levels were expressed as log10 pg/mL. Data are presented as scatterplots representing 
individual data points and a line indicating the mean value with Sd. Right, receiver operating characteristic (ROC) curves used to 
evaluate the ability of sTREM1 to diagnose IPA. p-values from sTREM1 levels comparisons were calculated using the Mann–Whitney 
U test. ****, p < 0.0001, ***, p < 0.001; **, p < 0.01.
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Course of IPA in immunocompetent or 
immunosuppressed Trem1−/− and Trem1+/+ mice
TREM1 gene expression induction, together with other 
genes of the pathway, was first seen in a previous 
transcriptomic analysis of murine lungs infected with 
A. fumigatus (Alcazar-Fuoli L., personal communica-
tion, Figure S1). To confirm these findings and to 
correlate increasing sTREM1 levels in response to A. 
fumigatus infection in mice, we assessed sTREM1 levels 
in lung homogenates of WT mice (Figure 3a). We 
observed that those levels were significantly increased 
after infection and then decreased gradually.
To further investigate the role of TREM1 in the 
context of IPA, the impact of TREM1 deficiency on 
susceptibility to aspergillosis was evaluated in experi-
mental murine models. Immunocompetent (intact) and 
immunosuppressed Trem1−/− and Trem1+/+ mice were 
inoculated with viable A. fumigatus conidia.
All intact Trem1+/+ and Trem1−/− mice survived to 
the A. fumigatus challenge (Figure 3b). As expected, 
immunosuppression resulted in enhanced susceptibility 
in both genetic backgrounds, however, immunosup-
pressed Trem1−/− mice showed earlier and more evi-












































































































































































Figure 2. a) sTREM1 levels measured in BAL samples from IPA and control (Ctrl) patients and stratified based on TREM1 genotypes of 
gene polymorphisms (rs2234237 and rs2234246). b) Cytokines levels measured in BAL samples from IPA and control patients and 
stratified based on TREM1 genotypes (rs2234237, rs2234246). Data are presented as box plots, with the bottom and top of the box 
indicating the first quartile to the third quartile, respectively. The bar within the box indicate the median value and the whiskers 
above and below the box show the 10th and the 90th percentiles. The dots indicate outliers. p-values were calculated using the 
Welch’s t-test. **, p < 0.01; *, p < 0.05.
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aspergillosis such as hunching, head tilting, and circling 
[30] compared to Trem1+/+ mice. Under immunosup-
pressed conditions, Trem1−/− mice showed a reduced 
survival that resulted statistically significant compared 
to Trem1+/+ mice (Figure 3b). About a 10% of Trem1+/+ 
mice survived the infection while none of the Trem1−/− 
survived. Median survival for Trem1−/− was 3 days 
while it was 4 days for the Trem1+/+ mice.
TREM1 deficiency showed a defective immune 
cell recruitment to the lungs
Immune cell responses and particularly myeloid cells 
are altered under the immunosuppressed conditions 
that are normally used in murine models of IPA [31]. 
For this reason and in order to see the intact role of 
TREM1 in response to A. fumigatus infection we used 
from now on a non-immunosuppressed infection 
model. Lung preparations from Trem1−/− and Trem1+/ 
+ mice were analyzed on 2, 3 and 5 dpi. Innate immune 
response was evaluated by the presence of granulocytes 
(Gr-1+ CD11b+) and monocytes (Gr-1-CD11b+) 
(Figure 4a, Figure 4b). Aspergillus instillation induced 
an important amount of both populations after 2 dpi. 
In the case of Trem1−/- infected mice, granulocytes and 
monocytes were strongly diminished in comparison 
with infected WT mice. No significant differences 
were observed in alveolar macrophage numbers in 
either strains (data not shown). Lymphocyte recruit-
ment was determined by the presence of CD3+ (T- 
lymphocytes), and CD4+, CD8+ and CD19+ (B-lym-
phocytes) (Figure 4c, Figure 4d). A rapid recruitment of 
lymphocytes was detected after 2 dpi on WT mice. In 
the case of Trem1−/- infected mice, minimal levels of 
CD3+ and CD19+ cells were detected at 2 dpi and a 
delayed lymphocytic response was detected from 3 dpi.
Lungs from TREM1-deficient mice have 
decreased histological evidence of 
inflammation
Histological examination of lungs harvested from mice 
at 2 dpi showed that TREM1-deficient animals had less 
evidence of inflammation when compared to WT 




































Figure 3. a) sTREM1 concentrations in lung homogenates from WT mice during A. fumigatus infection at different times (D2, 2 days; 
D3, 3 days; D5, 5 days). Values are represented as bar plots with mean ± SEM. p-values were calculated using the Mann–Whitney U 
test. ****, p < 0.0001; **, p < 0.01. b) Comparison of survival rate of WT mice (Trem1+/+; black lines with triangles) and TREM1- 
deficient mice (Trem1−/−; black lines with squares) to IPA. Intact mice (black lines with circle). Data represent the cumulative data of 
two separate experiments. The p-value of Kaplan–Meier curves comparison of immunosuppressed mice was determined with the 
use of the log-rank test. ***, p < 0.001.
576 L. BERNAL-MARTÍNEZ ET AL.
animals (Figure 5). Lung histology of WT mice showed 
that infection with A. fumigatus promoted remarkable 
lung inflammatory responses, including significant 
infiltration of inflammatory cells and destruction of 
blood vessels (Figure 5, arrows).
Deletion of TREM1 decreases cytokine 
responses against A. fumigatus in the murine 
lung
To correlate the pattern of inflammatory pathology 
observed in infected mice with the production of 
chemokines and cytokines known to be associated 
with the TREM1 inflammatory pathway, the chemo-
kine CXCL1/KC, the inflammatory cytokines IL-1β, 
TNF-α, and IL-6 as well as IL-10 and INF-γ, were 
measured in lung homogenates of Trem1−/− and 
Trem1+/+ mice. In line with our previous results, an 
induction of inflammatory cytokines was observed with 
maximum amounts at 2 dpi that decreased between 3 
and 5 dpi (Figure 6). Statistical differences were 
observed at day 2 between the WT and the Trem1−/− 
mice for CXCL1 and TNF-α. Of interest, differences for 
IL-1β were also maintained at 3 dpi and no induction 
and differences between groups were obtained for IL-10 
and IFN-γ (Figure 6).
In vitro activity of peritoneal macrophages 
isolated from Trem1−/− and Trem1+/+ mice
Phagocytosis quantification showed a trend toward a 














































































































































Figure 4. Whole lung cell suspensions from Trem1+/+ and Trem1−/− infected mice at different times (D2, 2 days; D3, 3 days; D5, 
5 days) and control mice were prepared, counted and stained with the mAbs indicated below for flow cytometry analyses (see 
Materials and Methods) using anti-CD11b-PECy7 and anti-Gr-1-PE (myeloid cells), anti-CD3-FITC, anti-CD4-APCCy7 and anti-CD8-PE (T 
cells), anti-CD19-Violet 421 (B cells). Viable cells were calculated on the basis of LIVE/DEAD violet-510 exclusion. Fluorescence scales 
are logarithmic. a) Representative dot plots of the myeloid cell populations at d2 pi in the myeloid gate to discriminate granulocytes 
(Gr-1+ CD11b+) from monocytes (Gr-1-CD11b+). b) Bar graphs represent total number of lung myeloid cells recovered from Trem1+/ 
+ (black bars) and Trem1−/− (white bars) from uninfected mice and after infection with A. fumigatus at different days post-infection. 
Calculations of the total number were performed from the frequencies obtained of each population and referred to the lung weight/ 
total animal weight. c) Representative dot plots of the lymphoid cell populations at d2 pi from lymphoid gating. Arrows indicate 
gating on CD3+ cells in order to study CD4+ and CD8+ cells. d) Bar graphs represent total number of lung lymphoid cells from both 
strain mice at indicated days after infection and uninfected mice calculated as described before. Data are mean ± SEM (n = 6). 
Comparisons were performed by using a two-tailed Student t-test. **, p < 0.01; *, p < 0.05.
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isolated from Trem1−/− mice (Figure 7a). To further inves-
tigate the synergy between TLRs and TREM1 in the 
immune responses against A. fumigatus, we analyzed the 
gene expression profile of primary murine macrophages 
within a background of complete TREM1 deficiency.
After A. fumigatus stimulation for 2 and 6 hours, 
the levels of gene expression of several genes related 
to TLR signaling and the TREM1 pathway inflam-
matory response were measured by real-time qPCR. 
Besides cytokines such as IL6, CXCL1, IL1β, and 
TNFα, we also evaluated gene expression of the 
receptors TLR2, TLR4, and the adaptor of MyD88.
In general gene expression was induced after 2 hours 
of infection in both genetic backgrounds. However after 
6 hours of A. fumigatus exposure, TREM1-deficient 
macrophages demonstrated significantly lower gene 
expression of TLR2, TLR4, and MyD88 receptors as 
well as a significant gene expression reduction of IL6 
and TNFα compared to the WT (Figure 7b).
Discussion
TREM1 is an important regulator of innate immunity 
that promotes the amplification of inflammatory sig-
nals initiated by TLRs and NOD-like receptors [32]. 
TREM1 has been characterized as a major player in 
the pathophysiology of acute inflammatory diseases 
of different etiologies such as acute myocardial 
infarction, atherosclerosis, and infectious diseases 
[11,33,34]. TREM1 is an immune receptor expressed 
on innate immune cells, such as neutrophils, mature 
monocytes, macrophages [9], and platelets [35]. 
TREM1 is also expressed on lung alveolar macro-
phages, and this tissue-specific pattern of expression 
has suggested a potential role for this molecule in the 
activation of local inflammatory response during lung 
infections [36].
Besides the cell receptor, a soluble form of TREM1 
(sTREM1) has been described [29]. sTREM1 may be 
produced from a splice variant or following the shedding 
Figure 5. Histology of lung sections of Trem1+/+ and Trem1−/− mice at day 2 post-infection versus non-infected controls, stained in 
HE. 10 x magnifications. Scale bars represent 10 μm.
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of membrane-bound TREM-1 by metalloproteinase- 
mediated proteolytic cleavage [37]. The biological func-
tion of sTREM is still unknown but based on data of 
other soluble forms of membrane receptors, sTREM1 
may act as a negative regulator of TREM1 signaling by 
neutralizing TREM1 ligands and thus interfere with the 
pro-inflammatory function of the TREM1 receptor [29]. 
sTREM1 can be detected in biological fluids during 
infection or inflammation, therefore, its relevance as a 
diagnostic biomarker is becoming important. There are 
several studies reporting that TREM1 plays a role in 
sepsis [38]. Plasma sTREM1 levels were positively corre-
lated with high scores of severity and mortality [39]. 
Serum levels of sTREM1 have also been reported to 
predict bacteremia in patients with community-acquired 
pneumonia [40]. In a recent study, the association 
between serum sTREM1 levels and pulmonary tubercu-
losis (TB) showed that serum levels were significantly 
increased in TB patients and these higher serum levels 
correlated with disease severity and treatment out-
comes [41].
A clear pathological hallmark of IPA is the pulmonary 
involvement which makes the BAL fluid examination a 
widely used procedure for the evaluation of patients with 
suspected aspergillosis. For instance, the detection of 
galactomannan, a polysaccharide present in the cell 
wall of Aspergillus species, in BAL fluids, has been advo-
cated as a sensitive test for diagnosing IPA (26). In this 
study, we identified a specific role of sTREM1 in the 
clinical presentation of IPA. Patients with IPA had sig-
nificantly higher levels of sTREM1 in BAL fluids when 
compared to control patients. Higher sTREM1 levels 
were also correlated with higher values of galactoman-
nan. We could discard this finding as attributable to a 
general response to infection since events of viral, bac-
terial, and other fungi were diagnosed within the control 
group (Table 1). Considering the specific expression of 
TREM1 in the lung, we could suggest that the use of 
TREM1 alone or in combination with other biomarkers 
present in respiratory samples could improve our capa-
city to anticipate a more accurate diagnosis for IPA.
Functional analysis of SNPs in TREM1 has shown 
that levels of sTREM1 can be regulated by individual 
variability at genomic level with a potential impact on 
the progression and severity of the disease and patient 
outcome [28]. For instance, a clinically relevant asso-
ciation of the rs2234237 T-allele with higher levels of 




































































Figure 6. Chemokines and cytokines in TREM1-deficient (Trem1−/−) or wild-type (Trem1+/+) mice with IPA. Chemokines and cytokines 
were determined by Luminex assay in lung homogenates from uninfected mice or from mice at 2 (D2), 3 (D3) or 5 (D5) days after 
intranasal inoculation of A. fumigatus conidia. Values are represented as bar plots with mean ± SEM. P-values were calculated using 
the Mann–Whitney U test. **, p < 0.01; *, p < 0.05.
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burn patients and in sepsis [27,42]. TREM family 
receptors have been also suggested to regulate the cel-
lular adhesion process and trans-endothelial migration 
[28]. In this context, the T allele at rs2234246 was 
associated with increased levels of sTREM1, affecting 
its expression levels, and with increased levels of soluble 
L-selectin which are thought to represent a homeostatic 
effort to limit excessive inflammation [28].
In our study, we stratified sTREM1 levels detected 
on the BAL of IPA and control patients according to 
TREM1 genotypes. We found changing levels of 
sTREM1 for rs2234237 and rs2234246 and we also 
found that TREM1 genotypes influenced the profile of 
proinflammatory cytokines. Based on the fact that in 
IPA higher levels of inflammatory mediators at the site 
of infection might indicate a more severe infection [19], 
we could hypothesize that TREM1 genotypes associated 
with an increase of sTREM1 levels and alteration of 
pro-inflammatory cytokines production in response to 
Aspergillus infection may impact disease progression 
that can ultimately affect patient outcomes.
We found that humans with pulmonary 
Aspergillosis manifested elevated levels of sTREM1 in 
BALs. Accordingly, mice infected with A. fumigatus 
showed increased lung sTREM1 levels (Figure 3a). In 
vivo, the role of TREM1 has been characterized in 
experimental murine models of microbial sepsis, infec-
tion with influenza virus, Leishmania major and other 
bacterial infections, in which suppression of TREM1 
signaling conferred significant protection [43–45]. In 
these models, protection was associated with reduced 
severe inflammation and diminished expression of pro- 
inflammatory cytokines [46]. In the case of A. fumiga-
tus infections, although reduced cytokine-driven 
inflammation can contribute to less damage in the 
lungs, impaired innate immune response and a lower 
capacity to mount early cytokine responses represent a 
primary risk factor for susceptibility, particularly in an 
immunosuppressed host [47]. In this sense, our study 
showed that, compared to WT mice, immunosup-
pressed Trem1−/- mice were more susceptible to asper-
gillosis. We found that both granulocytes and 
monocytes were recruited after infection in the murine 
lungs although cell recruitment was affected in the 
TREM1–deficiency setting. Granulocytes and mono-
cytes were diminished in Trem1−/- infected mice com-
pared to infected WT mice at 2 dpi. Fungal burden was 
checked in both groups (data not shown) to discard 
that the observed differences were not a consequence of 
differential fungal growth in the lungs. Furthermore, 
we showed that the difference in the amount of gran-
ulocytes and monocytes was still maintained after 5 dpi 
and they were below the initial values in the Trem1−/- 
background. Since recruitment and activation of poly-
morphonuclear neutrophils and mononuclear cells into 
the lungs is a crucial event in the early phases of IPA 
[48], we could attribute an increased susceptibility of 
Trem1−/- mice to an impaired pulmonary inflammation 
in response to A. fumigatus that impacted survival in 
the immunosuppressed host.
The innate immune response during Aspergillus 
infection triggers the development of an acquired 
immune response inducing the development of diverse 
CD4 T-cell responses that include T helper (Th) 1, Th2, 
Th17, and regulatory T (Treg) cells. In this sense, our 
results suggest an impaired immune response charac-
terized by diminished recruitment of T-cells (CD3, 
CD4, and CD8) and B-cells (CD19) to the lungs of 
Trem1−/- mice, especially at 2 dpi.
Histological visualization of lungs agreed with 
above-mentioned results and showed that infection 
with A. fumigatus produced lung inflammatory 
responses in both murine genetic backgrounds. 
However, WT mice showed a significant infiltration 
of inflammatory cells and it was possible to appreci-
ate destruction of blood vessels. As described before 
[28], an important role of TREM1 has been reported 
in cellular adhesion and trans-endothelial migration 
of neutrophils and monocytes. The histological pat-
tern of Trem1−/- mice would correlate with an 
impaired recruitment of inflammatory cells in the 
lungs and an apparent decrease of tissue damage 
due to the absence of TREM1. Although we could 
hypothesize that suppression of the TREM1 pathway 
may be beneficial for the pathological processes asso-
ciated with IPA, our results indicate a higher suscept-
ibility to infection by A. fumigatus. This agrees with 
fact that a right balance between moderating exces-
sive inflammation while preserving the capacity for 
microbial control is required for a successful resolu-
tion of A. fumigatus infections [7].
The recognition of Aspergillus conidia induces the 
expression of proinflammatory chemokines and cyto-
kines [10;11]. In line with previous results, we observed 
that the complete deficiency of the receptor was asso-
ciated with decreased Aspergillus-induced pro-inflam-
matory cytokine responses. The production of CXCL1, 
IL-1β, TNF, and IL-6 was decreased in the lungs of 
Trem1−/- mice at early stages on the infection (2 dpi). 
Time course pro-inflammatory cytokine profiles in 
Trem1+/+ mice (Figure 6), followed the same pattern 
than the detection of sTREM1 (Figure 3a). While pro- 
inflammatory cytokines and sTREM1 levels decreased 
at 3 dpi, the number of immune cell was still increasing 
(Figure 4). These findings agree with the hypothesis 
that this soluble form can be neutralizing the 
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production of cytokines [29] but it does not mediate a 
direct effect in the influx of immune cells.
The early control of microbe’s invasion primarily 
depends on professional phagocytes such as neutrophils 
and macrophages. In vitro studies have suggested that 
TREM1 may enhance phagocytosis [49]. In this study, 
we observed that the capacity of phagocytosis of A. 
fumigatus conidia was slightly reduced in the absence 
of TREM1. In addition, gene expression levels of TLR2, 
TLR4, the adaptor protein MyD88 as well as the pro- 
inflammatory cytokines IL-6, CXCL1, MCP1, IL1β, and 
TNFα, were quantified in order to corroborate the 
hypothesis of a synergistic effect between TREM1 and 
inflammatory reactions mediated by TLR4 and TLR2. 
Using murine macrophages isolated from Trem1+/+ and 
Trem1−/- mice, we observed a decreased expression of 
all the studied genes in the absence of TREM1 after 
6 hours of A. fumigatus challenge. These in vitro studies 
suggest a role for TREM1 in the recognition of A. 
fumigatus and support the role of TREM1 as an impor-
tant modulator of the inflammatory response against A. 
fumigatus. From a mechanistic point of view, we could 
suggest that TREM1 acts as a supplementary molecule 
amplifying the immune response, but not initially indu-
cing it, since its absence does not suppress completely 
the expression of TLR2 and TLR4. These receptors are 
important for the recruitment of polymorphonuclear 
cells to the lungs during IPA. The fact that the expres-
sion of the TLR-MyD88 pathway is reduced in condi-
tions of TREM1 deficiency will impact the response to 
A. fumigatus by restraining the release of cytokines and 
chemokines and less effective recruitment of immune 
cells to the lungs.
Collectively, our data provide evidence for a poten-
tial diagnostic value of sTREM1 in IPA. Initial findings 
on TREM1 functionality suggest that the impact of 
TREM1 SNPs in IPA should be further investigated. 
In addition, we showed a role of TREM1 on antifungal 
host defense against A. fumigatus in a murine model of 
IPA. TREM1 deficiency in mice, increased susceptibil-
ity to infection in an immunosuppressed murine model 
of IPA. Based on our findings, we can suggest that 
TREM1 deficiency mediates susceptibility against 















Figure 7. a) Percentage of phagocytosis of murine macrophages isolated from the peritoneal cavity of Trem1−/− or Trem1+/+ mice 
and challenged with A. fumigatus for 1 hour. b) Fold change in gene expression levels of TLR2, TLR4, MyD88, CXCL1, IL1β, IL6 and 
TNFα in murine macrophages isolated from the peritoneal cavity of Trem1−/− or Trem1+/+ mice and challenged with A. fumigatus for 
2 and 6 hours. Values are represented as bar plots with mean ± SEM. p-values were calculated using the Mann–Whitney U test. **, 
p < 0.01; *, p < 0.05.
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immune responses and impaired pro-inflammatory 
cytokine response.
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